Search research articles
Contact Us
Filters
Showing results (231-240 of 239) with videos related to
Page
of 24
Sort By:
You have reached the last page of results.
This site can display upto 239 results.
International Journal of Radiation Oncology, Biology, Physics
|
September 7, 1999
A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme
M D Groves, M H Maor, C Meyers, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 15, 2002
Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas
V A Levin, W K A Yung, J Bruner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2000
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas
H A Fine, W D Figg, K Jaeckle, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 5, 1998
Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma
M D Prados, C B Scott, M Rotman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2000
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme
V A Levin, J H Uhm, K A Jaeckle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 29, 1998
Gamma-ray mutagen sensitivity and survival in patients with glioma
A J Sigurdson, M L Bondy, K R Hess, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group
W K Yung, M D Prados, R Yaya-Tur, et al.
British Journal of Cancer
|
August 17, 2000
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
W K Yung, R E Albright, J Olson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 9, 1998
Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors
M D Prados, D A Larson, K Lamborn, et al.
Page
of 24
Search research articles
Search
Showing results (231-240 of 239) with videos related to
Sort By:
Page
of 24
You have reached the last page of results.
This site can display upto 239 results.
International Journal of Radiation Oncology, Biology, Physics
|
September 7, 1999
A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme
M D Groves, M H Maor, C Meyers, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 15, 2002
Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas
V A Levin, W K A Yung, J Bruner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2000
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas
H A Fine, W D Figg, K Jaeckle, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 5, 1998
Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma
M D Prados, C B Scott, M Rotman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2000
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme
V A Levin, J H Uhm, K A Jaeckle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 29, 1998
Gamma-ray mutagen sensitivity and survival in patients with glioma
A J Sigurdson, M L Bondy, K R Hess, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group
W K Yung, M D Prados, R Yaya-Tur, et al.
British Journal of Cancer
|
August 17, 2000
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
W K Yung, R E Albright, J Olson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 9, 1998
Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors
M D Prados, D A Larson, K Lamborn, et al.
Page
of 24